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Abstract
Objective
To determine the optimal vital sign predictor of adverse maternal outcomes in women with
hypovolemic shock secondary to obstetric hemorrhage and to develop thresholds for refer-
ral/intensive monitoring and need for urgent intervention to inform a vital sign alert device
for low-resource settings.
Study Design
We conducted secondary analyses of a dataset of pregnant/postpartum women with hypo-
volemic shock in low-resource settings (n = 958). Using receiver-operating curve analysis,
we evaluated the predictive ability of pulse, systolic blood pressure, diastolic blood pres-
sure, shock index, mean arterial pressure, and pulse pressure for three adverse maternal
outcomes: (1) death, (2) severe maternal outcome (death or severe end organ dysfunction
morbidity); and (3) a combined severe maternal and critical interventions outcome compris-
ing death, severe end organ dysfunction morbidity, intensive care admission, blood transfu-
sion 5 units, or emergency hysterectomy. Two threshold parameters with optimal rule-in
and rule-out characteristics were selected based on sensitivities, specificities, and positive
and negative predictive values.
Results
Shock index was consistently among the top two predictors across adverse maternal out-
comes. Its discriminatory ability was significantly better than pulse and pulse pressure for
maternal death (p<0.05 and p<0.01, respectively), diastolic blood pressure and pulse pres-
sure for severe maternal outcome (p<0.01), and systolic and diastolic blood pressure, mean
arterial pressure and pulse pressure for severe maternal outcome and critical interventions
(p<0.01). A shock index threshold of 0.9 maintained high sensitivity (100.0) with clinical
practicality, 1.4 balanced specificity (range 70.0–74.8) with negative predictive value
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(range 93.2–99.2), and 1.7 further improved specificity (range 80.7–90.8) without
compromising negative predictive value (range 88.8–98.5).
Conclusions
For women with hypovolemic shock from obstetric hemorrhage, shock index was consis-
tently a strong predictor of all adverse outcomes. In lower-level facilities in low resource set-
tings, we recommend a shock index threshold of 0.9 indicating need for referral, 1.4
indicating urgent need for intervention in tertiary facilities and 1.7 indicating high chance
of adverse outcome. The vital sign alert device incorporated values 0.9 and 1.7; however,
all thresholds will be prospectively validated and clinical pathways for action appropriate to
setting established prior to clinical implementation.
Introduction
Approximately 6% of deliveries are complicated by obstetric hemorrhage [1]. Despite a well-
established evidence-base for clinical management of obstetric hemorrhage, it remains the
leading cause of maternal mortality and morbidity globally [2, 3]. The greatest burden of
obstetric hemorrhage is in low-resource settings [2] where deaths occur due to delays in diag-
nosis and management. Prompt identification and treatment are crucial to reduce hemor-
rhage-related maternal mortality and morbidity.
Visual estimation of blood loss is routinely used to assess severity and guide resuscitation;
however, blood loss is often underestimated [4]. Vital signs monitoring is key to hemodynamic
assessment [4], with thresholds for systolic blood pressure (SBP) and pulse used in clinical trig-
ger or early warning systems to prompt intervention [5–8]. Impending shock may be masked
by the hemodynamic changes of pregnancy, making conventional vital signs less useful [9],
and signs taken in isolation may miss impending deterioration.
Within the general population, shock index (SI), the ratio of pulse to SBP, is proposed as an
earlier marker of hemodynamic compromise than conventional vital signs [10]. Trauma litera-
ture suggests normal adult SI ranges 0.5–0.7 [11]. A few small studies have evaluated SI within
obstetric populations [12–15], none in low or middle income countries, and further research is
necessary to inform the clinical utility of SI as an early marker of shock, due to antepartum and
peripartum circulatory changes.
We sought to determine the optimal vital sign predictor for severe adverse maternal out-
comes among women in hypovolemic shock secondary to obstetric hemorrhage, and to
develop thresholds corresponding to early detection triggers for immediate referral or intensive
treatment for incorporation into a semi-automated handheld, vital sign alert (VSA) device
[16–18] which will be prospectively validated in subsequent work. The device would incorpo-
rate a traffic-light early warning system for shock in low-resource settings where delays in
detection of impending compromise adversely affect maternal health.
Materials and Methods
We compiled data from 967 women comprising pre-intervention/control participants from
four studies conducted by the Safe Motherhood Program at the University of California, San
Francisco that evaluated the effectiveness of the non-pneumatic anti-shock garment (NASG)
to reduce adverse maternal outcomes for women with hypovolemic shock secondary to severe
Adverse Maternal Outcome and Shock Index
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obstetric hemorrhage: Egypt 2004 (n = 158), Egypt 2006–2008 (n = 432), Nigeria 2004–2007
(n = 182) and Zambia and Zimbabwe 2007–2012 (n = 195). Detailed descriptions of these stud-
ies have been published elsewhere [19–21]. Three of these studies, based at the tertiary level,
followed a quasi-experimental design where a pre-intervention period was temporally followed
by an NASG intervention period, and one was a cluster-randomized control trial (CRCT) of
NASG application at the primary health clinic (PHC) level, prior to transport to tertiary facility
for definitive treatment. The pre-intervention/control participants in all studies received stan-
dardized evidence-based hemorrhage and shock management [22]. Women in all trials were
eligible for study participation if they reached a threshold estimated blood loss and one or
more of the following: SBP 100 mmHg and/or pulse 100 BPM. In the tertiary facility stud-
ies in Egypt and Nigeria, the threshold estimated blood loss was>750ml, while in the Zambia
and Zimbabwe PHC-enrolled study the threshold EBL was>500 mL. The majority of facilities
were under-staffed, under-resourced, and characterized by long delays in obtaining definitive
care (surgery, blood transfusions). As a secondary analysis of de-identified data, no further
institutional review board approval was required for the current analysis. Initial study proto-
cols, including informed consent procedures, were approved by institutional review boards at
the University of California, San Francisco, and for each study, respectively, by the following
institutions: University of Zambia, Lusaka Research Ethics Committee; Medical Research
Council of Zimbabwe; Department of Reproductive Health and Research of the World Health
Organization Ethics Review Committee; National Reproductive Health Research Committee of
the Nigerian Federal Ministry of Health, El Galaa Maternity Teaching Hospital; Assiut Univer-
sity Women’s Health Center; Alexandria University Teaching Hospital; and Al Minya Univer-
sity Teaching Hospital. All women provided written or thumbprint (if illiterate) informed
consent for study participation; all ethics committees provided a waiver of consent from
women who were unconscious or confused at time of admission until they recovered or written
consent was obtained from a relative as proxy.
We excluded 1 individual who participated in the Zambia trial but was lost to follow-up and
had no outcome data for death, and 8 individuals across all studies that had no vital sign data
recorded or whose vital signs were indicated as non-palpable. Participants missing other pre-
dictors or outcomes were retained, resulting in a final analytic sample of 958 participants.
Measures
The data analyzed were based on data captured from the parent studies in which, upon enroll-
ment, patients’ vital signs, level of consciousness, urine output, blood loss, IV fluids, blood
products transfused and uterotonics administered were recorded at 15 minute intervals, until
the cause of bleeding was identified and treated, vital signs were stable (SBP100mmHg,
pulse<100 BPM) for at least two hours, and blood loss had decreased to approximately 25–50
mL per hour. Predictor variables for this analysis were values at the measurement interval with
the highest SI (pulse/SBP) within the first hour after study entry. Variables included pulse,
SBP, diastolic blood pressure (DBP), mean arterial pressure (MAP = (2 x DBP + SBP)/3), SI
(pulse/SBP), and pulse pressure (SBP-DBP). Severe shock at study entry was defined as MAP
less than 60 mmHg, below which perfusion of vital organs has been proposed to be inadequate
[23–25]. BP was measured via an automated blood pressure device or auscultatory technique
with mercury sphygmomanometer.
Outcomes comprised any severe adverse maternal event related to obstetric hemorrhage,
and included organ system dysfunction-based criteria and intervention-based criteria.
Although the outcomes for the original trials were determined prior to the development of the
WHO “Near-Miss” criteria [26], they are very similar. The original outcomes for the studies
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were maternal mortality; end-organ system failure morbidity defined as clinically-diagnosed
major organ failure (respiratory, renal, neurological, cardiac) lasting for 24 hours post-resusci-
tation; and the intervention variables ICU admission, blood transfusion, and emergency hys-
terectomy for intractable uterine atony. These outcomes were selected because in the majority
of our study sites, laboratory-based criteria (e.g., determining DIC by platelets), were not con-
sistently available. For the purposes of the present analysis we used the WHOmaternal near-
miss indicators for our outcomes [26]. We evaluated maternal status as 1) death or 2) severe
maternal outcome (SMO), a composite indicator of death or severe end-organ failure maternal
morbidity. Finally we combined SMO with the WHO intervention-based near-miss criteria
ICU admission, blood transfusion5 units and emergency hysterectomy (uterine atony diag-
noses only). WHO labels these as “critical interventions”; therefore, to be consistent with
WHO criteria, we called our composite indicator of SMO and the critical interventions
SMO-CI.
Analyses
We first evaluated the area under the curve (AUC) and associated 95% confidence interval for
each of the predictors with each of the maternal outcomes using non-parametric receiver-oper-
ating curve (ROC) analysis [27]. We then tested for predictor equality of AUCs across the
three outcomes using chi-square tests adjusted by Bonferroni correction for multiple compari-
sons [28]. To evaluate the impact of having selected one ‘worst’ data point within the first hour,
we conducted a sensitivity analysis assessing the AUC of each predictor and outcome combina-
tion using the following data points: 1) highest shock index (highest pulse and lowest systolic
blood pressure; 2) highest pulse; 3) lowest systolic blood pressure; and 4) lowest mean arterial
pressure. We calculated sensitivities, specificities, and positive and negative predictive values
for four potential thresholds of SI to select the two optimal thresholds indicating need for refer-
ral to higher-level care and need for intensive treatment. The two potential lower thresholds
were selected based on proposed thresholds from the literature [11, 13, 15, 29, 30] combined
with review of false positives below each threshold from our data. The two upper thresholds
were derived from the 95%, 98% and 99% specificity centiles of our outcomes, and a previous
analysis of severe postpartum blood loss among women in a higher resourced setting [15]. The
thresholds were picked to allow flexibility in clinical utility: the lower threshold to allow a rule
out test (i.e., high sensitivity and negative prediction) while the higher threshold an optimal
rule in test (i.e. high specificity and positive prediction). Results were not adjusted for the dif-
ferent treatments received by study participants. We conducted sensitivity analyses to deter-
mine whether our AUC results were robust across the two contexts in which participants
entered our study: at the PHC (Zambia and Zimbabwe) and the tertiary care facility level
(Egypt and Nigeria), through modeling interaction terms for vital sign predictors by context
within a series of logistic regression models. All analyses were conducted using Stata version
12.0 (StataCorp, College Station, TX). Differences were considered statistically significant
where p<0.05.
Results
Demographics and participants’ status at the time of study entry are presented in Table 1. The
mean age of study participants was 28.3 (SD 6.4) and median parity was 2 (IQR 1–4). At study
entry, median estimated blood loss was 1000 mL (IQR 750–1500). Most participants entered
the study in normal consciousness (57.7%) and 41.6% had altered consciousness. The most
common hemorrhage etiologies were uterine atony (32.9%), complications of abortion
Adverse Maternal Outcome and Shock Index
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(15.5%), retained placenta (12.0%) and ectopic pregnancy (10.6%). One-quarter (24.4%) were
in severe shock (MAP<60 mmHg).
Distributions of vital signs at study entry are presented in Table 2. The proportion of
women who developed each outcome was as follows: death (n = 39, 4.1%), SMO (n = 63,
6.6%), SMO-CI (n = 150, 15.7%).
Table 3 presents the performance of each vital sign in predicting each of the three adverse
outcomes. For death, SI and SBP had the highest AUC value at 0.87 (95% CI 0.80–0.94), which
Table 2. Distribution of Vital Sign Values.
Vital Sign N Median (IQR)
SI 952 1.3 (1.1–1.5)
Pulse 956 117 (110–122)
Systolic BP 954 90 (80–100)
Diastolic BP 863 59 (50–60)
MAP 863 68.7 (60–73.3)
Pulse Pressure 863 34 (30–40)
SI: shock index; BP: blood pressure; MAP: mean arterial pressure.
doi:10.1371/journal.pone.0148729.t002
Table 1. Participant Characteristics.
Characteristic n %
Age c 28.3 (6.4) a
Parity d 2 (1–4) b
Level of Consciousness
Normal 550 57.7
Altered 397 41.6
Under anesthesia 7 0.7
Estimated Blood Loss at Study Entry e 1000 (750–1500) b
Hemorrhage Diagnosis
Uterine Atony 315 32.9
Complications of Abortion 148 15.5
Retained Placenta 115 12.0
Ectopic Pregnancy 104 10.9
Abruptio Placenta 84 8.8
Ruptured Uterus 51 5.3
Placenta Previa 49 5.1
Lacerations 40 4.2
Other 28 2.9
Molar Pregnancy 12 1.3
Missing 6 0.6
Placenta Accreta 6 0.6
MAP<60c 233 24.4
MAP: mean arterial pressure.
aMean (SD)
bMedian (Quartiles)
c n = 956
dn = 935
en = 640.
doi:10.1371/journal.pone.0148729.t001
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was significantly higher than pulse (p<0.05) and pulse pressure (p<0.01). For SMO, SI and
pulse had the highest AUC value at 0.80 (95% CI 0.73–0.87) and 0.80 (95% CI 0.74–0.86),
respectively, and were significantly higher than DBP and pulse pressure (p<0.01). Pulse and SI
had the highest AUC values for SMO-CI, at 0.80 (95% CI 0.76–0.83) and 0.76 (95% CI: 0.71–
0.81), respectively. For SMO-CI, the AUC for SI was significantly higher than for SBP, DBP,
MAP and pulse pressure (p<0.01). We chose to develop our vital sign thresholds based on SI
because it was one of the top two vital sign predictors across all three maternal status and criti-
cal clinical intervention outcomes. Fig 1 presents the ROC curves for shock index across the
three outcomes. Our sensitivity analyses indicated that AUC values did not differ significantly
across study entry context (not shown). While the AUC results did not support SI as the supe-
rior predictor across all adverse maternal outcomes, the combined pattern of magnitude and
statistical difference suggests it is the most consistent predictor.
The proportion of women with SI greater than each of the thresholds evaluated is as follows:
SI 0.7: 99.6%, SI 0.9: 95.0%, SI 1.4: 32.3% and SI 1.7: 13.8% (not shown). The perfor-
mance of SI 0.7, the upper limit of normal SI for the non-pregnant population [29], and
SI 0.9 (equivalent to pulse 100/110 SBP), the proposed upper limit of normal SI immediately
postpartum [13], are presented in Table 4. At SI 0.7, sensitivity for all adverse outcomes is
very high (100.0) and specificity is very low (range 0.4–0.5), indicating that nearly all positives
are correctly identified as such, while many negatives are classified as false positives. Sensitivi-
ties are slightly lower (range 93.9–100.0) and specificities are slightly higher (range 4.9–5.3) at
SI 0.9 compared to SI 0.7; very few study participants had SI< 0.7 (0.4%) or SI< 0.9
(5.2%). SI 0.9 performed better than or similarly to SI 0.7 for all outcomes, thus SI 0.9 was
chosen as the lower of the two action thresholds, indicating need for referral to tertiary care or
intensive monitoring within tertiary care. As all of the women in the study had hypovolemic
shock, the high rate of positive test results is clinically acceptable.
Table 5 presents the SI centile values at 60%, 80%, 95%, 98% and 99% specificity. Using
common values from Table 5, we selected thresholds of SI 1.4 and SI 1.7 for further analy-
sis. Examples of vital sign combinations that represent these thresholds are as follows: pulse
112 and SBP 80 for SI 1.4, and pulse 130 combined with SBP 70 for 1.7. The performance of
these thresholds to identify women at highest risk of adverse maternal outcome is shown in
Table 6. Comparing SI 1.4 to SI 1.7, specificity is maximized for all outcomes at SI 1.7
Table 3. AUC Values (95% Confidence Intervals) of Vital Sign Discrimination Accuracy for Adverse
Maternal Outcomes.
Vital Sign N Death SMO SMO-CI
SI 952 0.87 (0.80–0.94) 0.80 (0.73–0.87) 0.76 (0.71–0.81)
Systolic BP 954 0.87 (0.80–0.94) 0.77 (0.70–0.85) 0.69 (0.64–0.75)##
Diastolic BP 863 0.81 (0.71–0.90) 0.69 (0.63–0.74) ## 0.69 (0.63–0.75) ##
Pulse 956 0.78 (0.69–0.87) # 0.80 (0.74–0.86) 0.80 (0.76–0.83)
MAP 863 0.83 (0.76–0.91) 0.76 (0.68–0.84) 0.70 (0.65–0.76)##
Pulse Pressure 863 0.39 (0.26–0.51) ## 0.51 (0.42–0.60) ## 0.50 (0.45–0.56)##
AUC: area under the curve; SI: shock index; BP: blood pressure; MAP: mean arterial pressure; SMO:
severe maternal outcome (death or severe end-organ failure maternal morbidity); SMO-CI: severe maternal
outcome or critical intervention (intensive care unit admission, blood transfusion 5 units or emergency
hysterectomy).
Results of signiﬁcance testing for equality of AUCs using Bonferroni-adjusted chi-square test, with SI as
reference: # Signiﬁcantly worse than SI (P<0.05)
and ## Signiﬁcantly worse than SI (P<0.01).
doi:10.1371/journal.pone.0148729.t003
Adverse Maternal Outcome and Shock Index
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Fig 1. ROCCurves of Shock Index on Outcomes: Died, SMO, and SMO-CI.
doi:10.1371/journal.pone.0148729.g001
Adverse Maternal Outcome and Shock Index
PLOS ONE | DOI:10.1371/journal.pone.0148729 February 22, 2016 7 / 12
(range 70.0–74.8 vs. range 88.5–90.8, respectively) with a corresponding increase in positive
prediction (range 10.7–34.2 vs. range 19.8–43.5%, respectively); while sensitivities are lower at
SI 1.7 (range 38.3–68.4 vs. 70.5–86.8, respectively) but with a corresponding negative predic-
tive values of 88.8–98.5. Similarly, slightly higher negative predictive values are achieved with
SI 1.4 (range 93.2–99.2) due to the higher sensitivities (range 70.5 to 86.8). The selection of
which higher threshold to use according to the data for clinical use or for incorporation into
the VSA device in development will depend on the clinical setting and existing referral path-
ways, as both thresholds SI 1.4 and 1.7 may be important for identifying individuals in need
of urgent care and resuscitation, dependent upon context.
Discussion
Our analysis found SI to be the most consistent predictor across a selection of severe maternal
outcomes and critical clinical indicators in women with hypovolemic shock secondary to
obstetric hemorrhage. High sensitivity combined with clinically practical specificity drove our
choice of SI 0.9 as the threshold for referral to a tertiary facility capable of comprehensive
emergency obstetric care or rigorous monitoring within such a context. We chose a higher
threshold of SI 1.4 to indicate need for intensive intervention because this value maximized
identification of women needing rapid resuscitation balanced with high sensitivity and negative
predictive value. However, for the purposes of clinical validation of the VSA device, an urgent
resuscitation threshold of SI 1.7 was implemented in order reduce the rate of false positives
and loss of trust in the VSA device at its inception; however all 3 thresholds will be evaluated
prospectively. Such a validation process will help to further refine the higher action threshold,
as it may vary based on clinical context and population.
Previous research has suggested a normal SI range of 0.7–0.9 for obstetric populations, with
0.9 representing the transition into abnormality [13]. Research with non-pregnant populations
Table 4. Performance of SI0.7 and SI0.9 in Predicting Adverse Maternal Outcomes.
Outcome SI Threshold Sensitivity (95% CI) Speciﬁcity (95% CI) PPV (95% CI) NPV (95% CI) Prevalence % (n)
Died SI0.7 100.0 (90.7–100.0) 0.4 (0.1–1.1) 4.0 (2.8–5.5) 100.0 (39.8–100.0) 4.1 (39)
SI0.9 100.0 (90.7–100.0) 5.3 (3.9–6.9) 4.2 (3.0–5.7) 100 (92.6–100.0)
SMO SI0.7 100.0 (94.2–100.0) 0.5 (0.1–1.2) 6.6 (5.1–8.3) 100.0 (39.8–100.0) 6.6 (63)
SI0.9 95.2 (86.5–99.0) 5.1 (3.7–6.7) 6.5 (5.0–8.4) 93.8 (82.8–98.7)
SMO-CI ISI0.7 100.0 (97.6–100.0) 0.5 (0.1–1.3) 15.7 (13.5–18.2) 100.0 (39.8–100.0) 15.7 (150)
SI0.9 94.0 (88.8–97.2) 4.9 (3.5–6.6) 15.5 (13.2–18.0) 81.3 (67.4–91.1)
SI: shock index; SMO: severe maternal outcome (death or severe end-organ failure maternal morbidity); SMO-CI: severe maternal outcome or critical
intervention (intensive care unit admission, blood transfusion 5 units or emergency hysterectomy).
doi:10.1371/journal.pone.0148729.t004
Table 5. SI Values at Various Levels of Specificity by Adverse Maternal Outcome.
Outcome 60% Speciﬁcity 80% Speciﬁcity 95% Speciﬁcity 98% Speciﬁcity 99% Speciﬁcity
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Died 1.38 (1.36–1.40) 1.58 (1.55–1.61) 1.91 (1.86–1.95) 2.10 (2.04–2.16) 2.24 (2.17–2.30)
SMO 1.37 (1.35–1.39) 1.57 (1.54–1.60) 1.89 (1.85–1.94) 2.08 (2.12–2.13) 2.21 (2.15–2.28)
SMO-CI 1.35 (1.33–1.37) 1.53 (1.51–1.56) 1.83 (1.79–1.87) 2.00 (1.95–2.06) 2.13 (2.07–2.19)
SI: shock index; SMO: severe maternal outcome (death or severe end-organ failure maternal morbidity); SMO-CI: severe maternal outcome or critical
intervention (intensive care unit admission, blood transfusion 5 units or emergency hysterectomy).
doi:10.1371/journal.pone.0148729.t005
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confirms that an SI threshold of 0.9 indicates need for intensive management and a higher risk
of mortality [31, 32]. Ectopic pregnancy studies report a high correlation of rupture with simi-
lar SI values [12, 33]. One PPH study supported 0.9 as a referral threshold using multiple
adverse outcomes [15], and another reported a higher value of 1.1 as indicative of transfusion
requirement but suggested 1.0 for simplification of use within an acute obstetric emergency
[13]. Within our sample, a threshold of 0.9 had high sensitivity but low specificity; most
women with adverse outcomes were identified using this threshold, suggesting that it repre-
sents a relevant threshold for medical intervention and referral. The low specificity observed
for this threshold is clinically acceptable given our population of women already in hypovole-
mic shock. The broad range of obstetric hemorrhage etiologies across our participants supports
the generalizability of this alert threshold.
The literature on SI threshold indicating highest risk of adverse outcome is sparse. Trauma-
related mortality has been found to be significantly increased above SI 1.0, 1.4 and 1.8 [34]. For
postpartum hemorrhage, one study previously conducted by our research group within a
higher-resource setting selected SI1.7 as trigger for intensive resuscitation [15]. This thresh-
old held higher positive predictive value within the current analysis as well, although the out-
comes were not as severe in the former study. However, within the current population already
meeting the criteria for hypovolemic shock secondary to obstetric hemorrhage, our analysis
suggested a slightly lower value, SI1.4, to indicate urgent need for resuscitation. Given the
long delays that such women in low-resource areas face in transport and receipt of definitive
treatment upon arrival at tertiary facilities, this lower threshold prioritizes earlier recognition
and more rapid intensive treatment, which is more suitable for such a context. However, as
indicated above, both higher thresholds will be prospectively evaluated within a larger facility-
based sample.
This study represents a preliminary evaluation of SI as a predictor of adverse maternal out-
comes in women with obstetric hemorrhage/hypovolemic shock in low-resource settings. We
draw upon a large sample of women with a variety of obstetric hemorrhage etiologies, and pri-
oritize the most robust and salient outcome of mortality. However, the generalizability of our
findings is limited to similar clinical and population contexts, and certain characteristics of our
data and analysis represent limitations to our study, which may affect the interpretation of our
results. First, all women in the original studies were experiencing hypovolemic shock secondary
to severe obstetric hemorrhage; therefore, they already met the WHO definition of “near-miss”
[26]. Second, improved prediction capability is typically achieved with higher prevalence rates
than our most robust outcomes, death and SMO [35]. Our SMO-CI outcome which includes
ICU admission and blood transfusion, is more prevalent, but may be susceptible in low
resource settings to supply variability (availability of blood or presence of functioning ICU, or
Table 6. Performance of SI1.4 and SI1.7 in Predicting Adverse Maternal Outcomes.
Outcome SI Threshold Sensitivity (95% CI) Speciﬁcity (95% CI) PPV (95% CI) NPV (95% CI) Prevalence % (n)
Died SI1.4 86.8 (71.9–95.6) 70.0 (66.9–73.0) 10.7 (7.5–14.8) 99.2 (98.2–99.7) 4.1 (39)
SI1.7 68.4 (51.3–82.5) 88.5 (86.3–90.5) 19.8 (13.4–27.7) 98.5 (97.5–99.2)
SMO SI1.4 80.6 (68.6–89.6) 71.4 (68.3–74.3) 16.4 (12.5–21.1) 98.1 (96.8–99.0) 6.6 (63)
SI1.7 51.6 (38.6–64.5) 88.8 (86.6–90.8) 24.4 (17.3–32.7) 96.3 (94.8–97.5)
SMO-CI SI1.4 70.5 (62.5–77.7) 74.8 (71.7–77.8) 34.2 (28.9–39.8) 93.2 (91.0–95.0) 15.7 (150)
SI1.7 38.3 (30.4–46.6) 90.8 (88.6–92.7) 43.5 (34.9–52.4) 88.8 (86.4–90.9)
SI: shock index; SMO: severe maternal outcome (death or severe end-organ failure maternal morbidity); SMO-CI: severe maternal outcome or critical
intervention (intensive care unit admission, blood transfusion 5 units or emergency hysterectomy)
doi:10.1371/journal.pone.0148729.t006
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capable staff for ICU), the financial ability of patients to afford interventions, and other human
resource constraints prevalent in LMICs [19]. Third, no treatment data were included in this
analysis. Some women received IV fluids, uterotonics, procedures and surgical interventions
that may have influenced clinical trajectories between study entry and outcome. Future studies
on prediction of adverse outcome should include timing and impact of therapies on resuscita-
tion. Fourth, our vital sign measures were taken at the combined point of highest pulse and
lowest systolic blood pressure (i.e., highest shock index) within the first hour after study entry
which may have inadvertently biased our selection of shock index as the most discriminatory
predictor of adverse outcome. We evaluated this potential for bias within a sensitivity analysis
of AUC across four “worst” categories: shock index, pulse, systolic blood pressure and MAP
and report no substantial or consistent patterning; however, this remains a potential limitation.
Furthermore, our vital sign measures represent only one time point; subsequent work on shock
index should utilize repeated measures for a more robust analysis. Fifth, we included all indi-
viduals with data for each comparison, instead of conducting a complete case analysis; thus,
comparisons across each of the predictor and outcome combinations are affected by slightly
different missing data patterns. Sixth, we excluded several participants who were in the most
severe condition due to non-palpable vital signs, thus our analysis is more conservative. Finally,
the impetus for this analysis was to inform thresholds for a hand-held semi-automated early
warning VSA device incorporating a traffic-light warning system for hypertension and shock
designed for low-resource settings [16, 17]. Such a device can be utilized to improve referral
practices even among low-level community health providers including traditional birth atten-
dants; therefore, we did not consider ease of calculation in our threshold development [13, 36].
As suggested by Le Bas et al [13], recommending that referral or intervention be triggered
where pulse is greater than or equal to systolic blood pressure, indicating an SI threshold of 1.0,
may be useful in settings where health care workers are unable to compute the ratio of pulse to
SBP.
The developing evidence base on the utility of SI, strengthened by the results from our anal-
ysis, indicates a potential role for SI in early diagnosis and management of shock and for reduc-
ing adverse outcomes in obstetric populations. We suggest a lower SI threshold of 0.9
indicating need for referral to tertiary facility or rigorous monitoring within tertiary care.
Based on our results, we suggest higher SI thresholds of 1.4 to indicate the urgent need for
intensive treatment, and 1.7 as indicative of high risk of adverse event. Further research should
evaluate these thresholds prospectively and focus on implementing SI as a tool at multiple clin-
ical levels with different categories of care providers to maximize its utility within clinical
obstetric early warning systems [17, 18].
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